XNAS · IBB

-0.76% · -$1.64 · Vol 1.4M

Market closed · last close 4:00 PM ET · price as of 17:57:34 ET

IBB

iShares Biotechnology ETF

$214.76

Card

Relationship Map

Veridion Score

BETAFund score · valuation-exemptMEDIUM CONF · 4/5 factors

Wed Aug 26 · market closed · Markets closed · resumes Thu 9:30 ET · IBB

Methodology

Fund Flow absence reason unknown

IBB

iShares Biotechnology ETF

Wed Aug 26 · market closed · Markets closed · resumes Thu 9:30 ET

71/100

BUY BIAS

Fund-class market intelligence score across five applicable factors. Company valuation and earnings inputs are excluded.

71/ 100

Veridion Score

BUY BIAS · MEDIUM confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Momentum · attention · fund flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 4/5 factors with data · Wed Aug 26 · market closed · Markets closed · resumes Thu 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is IBB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move IBB next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Aug 26
Score
Score moved +25
46/NEUTRAL -> 71/BUY BIAS
Veridion score historySource
Feb 23
CongressChecking access
David P. Joyce sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 17
CongressChecking access
David P. Joyce sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 30
CongressChecking access
Carlos Curbelo sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 28
CongressChecking access
Richard L. Hanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
May 31
CongressChecking access
James French Hill purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
May 25
CongressChecking access
Carlos Curbelo purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About iShares Biotechnology ETF

Listed since

2001

Country

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$215.43

Day high

$216.07

Day low

$214.03

Previous close

$216.40

52W high

$216.96

-1.02% from high

52W low

$138.21

97% of range

Beta

0.52

Shares out

50.3M

Volume

1.4M

0.91× rel vol

Avg volume

1.5M

VWAP

$215.25

Price history computed in-house

+1.86%

+12.72%

+24.73%

+54.96%

YTD

+27.25%

SMA 50 $192.99 · above

SMA 200 $175.82 · above

52W position 97%

IBB overview

Veridion Score

Registered · 2026-08-26

4 of 5 factors measured

Latest receipt rows

David P. Joyce · Sale

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around IBB.Congress disclosuresOpen receipt and filing context for IBB.MethodologyReview score inputs, coverage rules, and limitations.

Financials

Company financial statements are not applicable for IBB.

SEC Form 4 ledger

IBB insider activity

iShares Biotechnology ETF

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not evaluated: the SEC filing index could not be read

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

No value-bearing Form 4 rows

The current Form 4 feed did not return value-bearing open-market rows for IBB.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in IBB

Congress tracker Open ticker disclosure ledger →

David P. JoyceSell

IBB Common Stock · Transaction Feb 23, 2017 · Filed May 8, 2019 · Amount pending receipt enrichment

Official filing ↗

David P. JoyceSell

IBB Common Stock · Transaction Feb 17, 2017 · Filed Jul 26, 2017 · Amount pending receipt enrichment

Official filing ↗

Carlos CurbeloSellspouse

Disclosed security · Transaction Dec 30, 2016 · Filed Jan 10, 2017 · $1,001 to $15,000

Official filing ↗

Richard L. HannaSell

IBB · Transaction Dec 28, 2016 · Filed Jan 18, 2017 · $1,001 to $15,000

Official filing ↗

James French HillBuy

IBB · Transaction May 31, 2016 · Filed Jul 12, 2016 · $15,001 to $50,000

Official filing ↗

Federal contracts

IBB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for IBB in this window.

Lobbying spend

IBB lobbying filings, year to date.

Registered lobbying filings matched to iShares Biotechnology ETF.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for IBB in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for IBB.

Options

Sovereign unlock shows live options positioning for IBB.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Follow $IBB

Why is IBB moving today?

What can move IBB next.

IBB overview

Related filings and maps

IBB insider activity

IBB contract awards, year to date.

IBB lobbying filings, year to date.

Cross-references from this score page.

What can move IBB next.

IBB insider activity

Cross-references from this score page.